Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.54 USD | -3.21% | -11.16% | +23.13% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.13% | 295M | |
+9.74% | 118B | |
+10.77% | 106B | |
-10.94% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.30% | 15.97B | |
+6.56% | 14.03B | |
+17.26% | 11.67B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Barclays Adjusts Price Target on Solid Biosciences to $21 From $8, Maintains Overweight Rating